Tag Archives: adaptive licensing

Adaptive Licensing: The Start of a Slow Revolution in Europe

By Peter O’ Donnell. So at last it’s happened. Adaptive licensing has leapt from the pages of learned journals into the real world of European regulation. Is this the beginning of the end of binary decision-making on the merits of a new medicine? Has a half-century of the “yes/no” authorization process peaked, to be replaced […]
Posted in Europe, Global, Guest Blog, Op-Ed, R&D, Regulatory, Safety | Also tagged , , , , | Leave a comment

For What it’s Worth: Study Probes Evolving Value Schemes

PharmaFutures’ Pathways to Value: Pharma in a Changing World explains how the industry may move forward to combine business imperatives and social mandates through new strategies for determining value and reimbursement for medicines. The study determines that collaboration across three fronts is needed to ensure that value is recognized and adapted over time, taking into […]
Posted in Emerging Markets, Europe, Market Access, pricing, R&D, Regulatory, Strategy | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta